From cell membrane to the nucleus: An emerging role of E-cadherin in gene transcriptional regulation

Journal of Cellular and Molecular Medicine

Volumn 18, Issue 9, 2014, Pages 1712-1719

  Du, Wenjun ^a   Liu, Xi ^b   Fan, Guiling ^a   Zhao, Xingsheng ^b   Sun, Yanying ^c   Wang, Tianzhen ^d   Zhao, Ran ^d   Wang, Guangyu ^d   Zhao, Ci ^d   Zhu, Yuanyuan ^d   Ye, Fei ^d   Jin, Xiaoming ^d   Zhang, Fengmin ^d   Zhong, Zhaohua ^d   Li, Xiaobo ^d  

^a SHANDONG UNIVERSITY   (China)

^b Inner Mongolia People's Hospital   (China)

^c QIQIHAR MEDICAL UNIVERSITY   (China)

^d HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Cell signalling; E cadherin; Gene expression

Indexed keywords

CADHERIN; CDH1 PROTEIN, HUMAN; GUANOSINE TRIPHOSPHATASE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN TYROSINE KINASE;

CELL MEMBRANE; CELL NUCLEUS; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; METABOLISM; PHYSIOLOGY; WNT SIGNALING PATHWAY;

CADHERINS; CELL MEMBRANE; CELL NUCLEUS; GENE EXPRESSION REGULATION; GTP PHOSPHOHYDROLASES; HUMANS; NF-KAPPA B; P120 GTPASE ACTIVATING PROTEIN; RECEPTOR PROTEIN-TYROSINE KINASES; TRANSCRIPTION, GENETIC; WNT SIGNALING PATHWAY;

EID: 84908210301     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12340     Document Type: Article

References (87)

1. van Roy F, Berx G. The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci. 2008; 65: 3756-88.
2. Sasaki CY, Lin HC, Passaniti A. Expression of E-cadherin reduces bcl-2 expression and increases sensitivity to etoposide-induced apoptosis. Int J Cancer. 2000; 86: 660-6.
3. Wang DS, Su L, Huang DH, et al. Downregulation of E-Cadherin enhances proliferation of head and neck cancer through transcriptional regulation of EGFR. Mol Cancer. 2011; 10: 116.
4. Strumane K, Bonnomet A, Stove C, et al. E-cadherin regulates human Nanos1, which interacts with p120ctn and induces tumor cell migration and invasion. Cancer Res. 2006; 66: 10007-15.
5. Onder TT, Gupta PB, Mani SA, et al. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res. 2008; 68: 3645-54.
6. Soncin F, Mohamet L, Ritson S, et al. E- cadherin acts as a regulator of transcripts associated with a wide range of cellular processes in mouse embryonic stem cells. PLoS ONE. 2011; 6: e21463.
7. Huber AH, Weis WI. The structure of the beta-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by beta-catenin. Cell. 2001; 105: 391-402.
8. Holland JD, Klaus A, Garratt AN, et al. Wnt signaling in stem and cancer stem cells. Curr Opin Cell Biol. 2013; 25: 254-64.
9. Gottardi CJ, Wong E, Gumbiner BM. E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner. J Cell Biol. 2001; 153: 1049-60.
10. Caca K, Kolligs FT, Ji X, et al. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer. Cell Growth Differ. 1999; 10: 369-76.
11. van de Wetering M, Barker N, Harkes IC, et al. Mutant E-cadherin breast cancer cells do not display constitutive Wnt signaling. Cancer Res. 2001; 61: 278-84.
12. Herzig M, Savarese F, Novatchkova M, et al. Tumor progression induced by the loss of E-cadherin independent of beta-catenin/Tcf-mediated Wnt signaling. Oncogene. 2007; 26: 2290-8.
13. Kuphal F, Behrens J. E-cadherin modulates Wnt-dependent transcription in colorectal cancer cells but does not alter Wnt-independent gene expression in fibroblasts. Exp Cell Res. 2006; 312: 457-67.
14. Ciruna B, Rossant J. FGF signaling regulates mesoderm cell fate specification and morphogenetic movement at the primitive streak. Dev Cell. 2001; 1: 37-49.
15. Kam Y, Quaranta V. Cadherin-bound beta-catenin feeds into the Wnt pathway upon adherens junctions dissociation: evidence for an intersection between beta-catenin pools. PLoS ONE. 2009; 4: e4580.
16. Thievessen I, Seifert HH, Swiatkowski S, et al. E-cadherin involved in inactivation of WNT/beta-catenin signalling in urothelial carcinoma and normal urothelial cells. Br J Cancer. 2003; 88: 1932-8.
17. Sanson B, White P, Vincent JP. Uncoupling cadherin-based adhesion from wingless signalling in Drosophila. Nature. 1996; 383: 627-30.
18. Heasman J, Crawford A, Goldstone K, et al. Overexpression of cadherins and underexpression of beta-catenin inhibit dorsal mesoderm induction in early Xenopus embryos. Cell. 1994; 79: 791-803.
19. Solanas G, Porta-de-la-Riva M, Agustí C, et al. E-cadherin controls beta-catenin and NF-kappaB transcriptional activity in mesenchymal gene expression. J Cell Sci. 2008; 121: 2224-34.
20. Syed V, Mak P, Du C, et al. Beta-catenin mediates alteration in cell proliferation, motility and invasion of prostate cancer cells by differential expression of E-cadherin and protein kinase D1. J Cell Biochem. 2008; 104: 82-95.
21. Orsulic S, Huber O, Aberle H, et al. E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation. J Cell Sci. 1999; 112: 1237-45.
22. Howard S, Deroo T, Fujita Y, et al. A positive role of cadherin in Wnt/beta-catenin signalling during epithelial-mesenchymal transition. PLoS ONE. 2011; 6: e23899.
23. Jamora C, DasGupta R, Kocieniewski P, et al. Links between signal transduction, transcription and adhesion in epithelial bud development. Nature. 2003; 422: 317-22.
24. Lemmon MA, Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell. 2010; 141: 1117-34.
25. Ochiai A, Akimoto S, Kanai Y, et al. c-erbB-2 gene product associates with catenins in human cancer cells. Biochem Biophys Res Commun. 1994; 205: 73-8.
26. Fedor-Chaiken M, Hein PW, Stewart JC, et al. E-cadherin binding modulates EGF receptor activation. Cell Commun Adhes. 2003; 10: 105-18.
27. Qian X, Karpova T, Sheppard AM, et al. E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases. EMBO J. 2004; 23: 1739-48.
28. Pece S, Gutkind JS. Signaling from E-cadherins to the MAPK pathway by the recruitment and activation of epidermal growth factor receptors upon cell-cell contact formation. J Biol Chem. 2000; 275: 41227-33.
29. Inge LJ, Barwe SP, D'Ambrosio J, et al. Soluble E-cadherin promotes cell survival by activating epidermal growth factor receptor. Exp Cell Res. 2011; 317: 838-48.
30. Brouxhon SM, Kyrkanides S, Teng X, et al. Soluble E-cadherin: a critical oncogene modulating receptor tyrosine kinases, MAPK and PI3K/Akt/mTOR signaling. Oncogene. 2014; 33: 225-35.
31. Perrais M, Chen X, Perez-Moreno M, et al. E-cadherin homophilic ligation inhibits cell growth and epidermal growth factor receptor signaling independently of other cell interactions. Mol Biol Cell. 2007; 18: 2013-25.
32. Kim S, Schein AJ, Nadel JA. E-cadherin promotes EGFR-mediated cell differentiation and MUC5AC mucin expression in cultured human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2005; 289: L1049-60.
33. Georgopoulos NT, Kirkwood LA, Walker DC, et al. Differential regulation of growth-promoting signalling pathways by E-cadherin. PLoS ONE. 2010; 5: e13621.
34. Song S, Eckerle S, Onichtchouk D, et al. Pou5f1-dependent EGF expression controls E-cadherin endocytosis, cell adhesion, and zebrafish epiboly movements. Dev Cell. 2013; 24: 486-501.
35. Grabowska MM, Sandhu B, Day ML. EGF promotes the shedding of soluble E-cadherin in an ADAM10-dependent manner in prostate epithelial cells. Cell Signal. 2012; 24: 532-8.
36. Zuo JH, Zhu W, Li MY, et al. Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin. J Cell Biochem. 2011; 112: 2508-17.
37. Cheng JC, Klausen C, Leung PC. Hydrogen peroxide mediates EGF-induced down-regulation of E-cadherin expression via p38 MAPK and snail in human ovarian cancer cells. Mol Endocrinol. 2010; 24: 1569-80.
38. Dürer U, Hartig R, Bang S, et al. TFF3 and EGF induce different migration patterns of intestinal epithelial cells in vitro and trigger increased internalization of E-cadherin. Cell Physiol Biochem. 2007; 20: 329-46.
39. Bryant DM, Kerr MC, Hammond LA, et al. EGF induces macropinocytosis and SNX1-modulated recycling of E-cadherin. J Cell Sci. 2007; 120: 1818-28.
40. Bryant DM, Wylie FG, Stow JL. Regulation of endocytosis, nuclear translocation, and signaling of fibroblast growth factor receptor 1 by E-cadherin. Mol Biol Cell. 2005; 16: 14-23.
41. Kang HG, Jenabi JM, Zhang J, et al. E-cadherin cell-cell adhesion in ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase. Cancer Res. 2007; 67: 3094-105.
42. Kovacs EM, Ali RG, McCormack AJ, et al. E-cadherin homophilic ligation directly signals through Rac and phosphatidylinositol 3-kinase to regulate adhesive contacts. J Biol Chem. 2002; 277: 6708-18.
43. Pece S, Chiariello M, Murga C, et al. Activation of the protein kinase Akt/PKB by the formation of E-cadherin-mediated cell-cell junctions. Evidence for the association of phosphatidylinositol 3-kinase with the E-cadherin adhesion complex. J Biol Chem. 1999; 274: 19347-51.
44. De Santis G, Miotti S, Mazzi M, et al. E-cadherin directly contributes to PI3K/AKT activation by engaging the PI3K-p85 regulatory subunit to adherens junctions of ovarian carcinoma cells. Oncogene. 2009; 28: 1206-17.
45. Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nature. 2002; 420: 629-35.
46. Welsh CF, Roovers K, Villanueva J, et al. Timing of cyclin D1 expression within G1 phase is controlled by Rho. Nat Cell Biol. 2001; 3: 950-7.
47. Olson MF, Paterson HF, Marshall CJ. Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1. Nature. 1998; 394: 295-9.
48. Noren NK, Niessen CM, Gumbiner BM, et al. Cadherin engagement regulates Rho family GTPases. J Biol Chem. 2001; 276: 33305-8.
49. Nakagawa M, Fukata M, Yamaga M, et al. Recruitment and activation of Rac1 by the formation of E-cadherin-mediated cell-cell adhesion sites. J Cell Sci. 2001; 114: 1829-38.
50. Goodwin M, Kovacs EM, Thoreson MA, et al. Minimal mutation of the cytoplasmic tail inhibits the ability of E-cadherin to activate Rac but not phosphatidylinositol 3-kinase: direct evidence of a role for cadherin-activated Rac signaling in adhesion and contact formation. J Biol Chem. 2003; 278: 20533-9.
51. Coniglio SJ, Jou TS, Symons M. Rac1 protects epithelial cells against anoikis. J Biol Chem. 2001; 276: 28113-20.
52. Hawkins PT, Eguinoa A, Qiu RG, et al. PDGF stimulates an increase in GTP-Rac via activation of phosphoinositide 3-kinase. Curr Biol. 1995; 5: 393-403.
53. Kim SH, Li Z, Sacks DB. E-cadherin-mediated cell-cell attachment activates Cdc42. J Biol Chem. 2000; 275: 36999-7005.
54. Priya R, Yap AS, Gomez GA. E-cadherin supports steady-state Rho signaling at the epithelial zonula adherens. Differentiation. 2013; 86: 133-40.
55. Nola S, Daigaku R, Smolarczyk K, et al. Ajuba is required for Rac activation and maintenance of E-cadherin adhesion. J Cell Biol. 2011; 195: 855-71.
56. Shewan AM, Maddugoda M, Kraemer A, et al. Myosin 2 is a key Rho kinase target necessary for the local concentration of E-cadherin at cell-cell contacts. Mol Biol Cell. 2005; 16: 4531-42.
57. Izumi G, Sakisaka T, Baba T, et al. Endocytosis of E-cadherin regulated by Rac and Cdc42 small G proteins through IQGAP1 and actin filaments. J Cell Biol. 2004; 166: 237-48.
58. Leibfried A, Fricke R, Morgan MJ, et al. Drosophila Cip4 and WASp define a branch of the Cdc42-Par6-aPKC pathway regulating E-cadherin endocytosis. Curr Biol. 2008; 18: 1639-48.
59. Wang B, Wylie FG, Teasdale RD, et al. Polarized trafficking of E-cadherin is regulated by Rac1 and Cdc42 in Madin-Darby canine kidney cells. Am J Physiol Cell Physiol. 2005; 288: C1411-9.
60. Shen Y, Hirsch DS, Sasiela CA, et al. Cdc42 regulates E-cadherin ubiquitination and degradation through an epidermal growth factor receptor to Src-mediated pathway. J Biol Chem. 2008; 283: 5127-37.
61. Tripathi V, Popescu NC, Zimonjic DB. DLC1 induces expression of E-cadherin in prostate cancer cells through Rho pathway and suppresses invasion. Oncogene. 2014; 33: 724-33.
62. Cowell CF, Yan IK, Eiseler T, et al. Loss of cell-cell contacts induces NF-kappaB via RhoA-mediated activation of protein kinase D1. J Cell Biochem. 2009; 106: 714-28.
63. Kuphal S, Poser I, Jobin C, et al. Loss of E-cadherin leads to upregulation of NFkappaB activity in malignant melanoma. Oncogene. 2004; 23: 8509-19.
64. Tong Z, Chakraborty S, Sung B, et al. Epidermal growth factor down-regulates the expression of neutrophil gelatinase-associated lipocalin (NGAL) through E-cadherin in pancreatic cancer cells. Cancer. 2011; 117: 2408-18.
65. Hu Z, Liu X, Tang Z, et al. Possible regulatory role of Snail in NF-kappaB-mediated changes in E-cadherin in gastric cancer. Oncol Rep. 2013; 29: 993-1000.
66. Zhang K, Zhaos J, Liu X, et al. Activation of NF-B upregulates Snail and consequent repression of E-cadherin in cholangiocarcinoma cell invasion. Hepatogastroenterology. 2011; 58: 1-7.
67. Chua HL, Bhat-Nakshatri P, Clare SE, et al. NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2. Oncogene. 2007; 26: 711-24.
68. Chen Z, Liu M, Liu X, et al. COX-2 regulates E-cadherin expression through the NF-kappaB/Snail signaling pathway in gastric cancer. Int J Mol Med. 2013; 32: 93-100.
69. Fukumoto Y, Shintani Y, Reynolds AB, et al. The regulatory or phosphorylation domain of p120 catenin controls E-cadherin dynamics at the plasma membrane. Exp Cell Res. 2008; 314: 52-67.
70. Park JI, Ji H, Jun S, et al. Frodo links Dishevelled to the p120-catenin/Kaiso pathway: distinct catenin subfamilies promote Wnt signals. Dev Cell. 2006; 11: 683-95.
71. Soto E, Yanagisawa M, Marlow LA, et al. p120 catenin induces opposing effects on tumor cell growth depending on E-cadherin expression. J Cell Biol. 2008; 183: 737-49.
72. Anastasiadis PZ. p120-ctn: a nexus for contextual signaling via Rho GTPases. Biochim Biophys Acta. 2007; 1773: 34-46.
73. Anastasiadis PZ, Reynolds AB. Regulation of Rho GTPases by p120-catenin. Curr Opin Cell Biol. 2001; 13: 604-10.
74. Villalonga P, Ridley AJ. Rho GTPases and cell cycle control. Growth Factors. 2006; 24: 159-64.
75. van Hengel J, Vanhoenacker P, Staes K, et al. Nuclear localization of the p120(ctn) Armadillo-like catenin is counteracted by a nuclear export signal and by E-cadherin expression. Proc Natl Acad Sci USA. 1999; 96: 7980-5.
76. Kelly KF, Spring CM, Otchere AA, et al. NLS-dependent nuclear localization of p120ctn is necessary to relieve Kaiso-mediated transcriptional repression. J Cell Sci. 2004; 117: 2675-86.
77. Daniel JM. Dancing in and out of the nucleus: p120(ctn) and the transcription factor Kaiso. Biochim Biophys Acta. 2007; 1773: 59-68.
78. Kim SW, Park JI, Spring CM, et al. Non-canonical Wnt signals are modulated by the Kaiso transcriptional repressor and p120-catenin. Nat Cell Biol. 2004; 6: 1212-20.
79. Park JI, Kim SW, Lyons JP, et al. Kaiso/p120-catenin and TCF/beta-catenin complexes coordinately regulate canonical Wnt gene targets. Dev Cell. 2005; 8: 843-54.
80. Spring CM, Kelly KF, O'Kelly I, et al. The catenin p120ctn inhibits Kaiso-mediated transcriptional repression of the beta-catenin/TCF target gene matrilysin. Exp Cell Res. 2005; 305: 253-65.
81. Hosking CR, Ulloa F, Hogan C, et al. The transcriptional repressor Glis2 is a novel binding partner for p120 catenin. Mol Biol Cell. 2007; 18: 1918-27.
82. Céspedes MV, Larriba MJ, Pavón MA, et al. Site-dependent E-cadherin cleavage and nuclear translocation in a metastatic colorectal cancer model. Am J Pathol. 2010; 177: 2067-79.
83. Barshishat M, Polak-Charcon S, Schwartz B. Butyrate regulates E-cadherin transcription, isoform expression and intracellular position in colon cancer cells. Br J Cancer. 2000; 82: 195-203.
84. Elston MS, Gill AJ, Conaglen JV, et al. Nuclear accumulation of e-cadherin correlates with loss of cytoplasmic membrane staining and invasion in pituitary adenomas. J Clin Endocrinol Metab. 2009; 94: 1436-42.
85. Fougner SL, Lekva T, Borota OC, et al. The expression of E-cadherin in somatotroph pituitary adenomas is related to tumor size, invasiveness, and somatostatin analog response. J Clin Endocrinol. 2010; 95: 2334-42.
86. Ohishi Y, Oda Y, Kurihara S, et al. Nuclear localization of E-cadherin but not beta-catenin in human ovarian granulosa cell tumours and normal ovarian follicles and ovarian stroma. Histopathology. 2011; 58: 423-32.
87. Ferber EC, Kajita M, Wadlow A, et al. A role for the cleaved cytoplasmic domain of E-cadherin in the nucleus. J Biol Chem. 2008; 283: 12691-700.